SYRS Syros: Sotuvning sof marjinal rentabelligi

syros.com (SYRS) - korporativ logo

Syros Pharmaceuticals (SYRS) uchun asosiy drayver saraton terapiyasi uchun genlarni boshqarish platformasi bo'lib, u patent kelishuvlari orqali pul oqimini generatsiya qiladi. Sof operatsion marja ushbu tendentsiyani aks ettiradi, bunda 0.00 ushbu baholash parametrini xarakterlaydi. Kelajakdagi istiqbollar onkologik sinovlar natijalariga bog'liq, potensial talab esa murakkab leykozlar uchun samarali davolash vositalarining yetishmasligi bilan belgilanadi.

syros.com (SYRS) - Sof marja 04.07.2022dan 29.03.2025gacha

Syros - tahliliy kesimlar va asosiy koʻrsatkichlar (SYRS)

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning barcha koʻrsatkichlari tahlili:Syros Pharmaceuticals Inc. - SYRS
Syros Pharmaceuticals Inc. tayyor mahsulotlari

Genomik tahlillarga asoslangan maqsadli leykoz terapiyasini ishlab chiqadigan Syros Pharmaceuticals (SYRS) uchun savdo marjasi innovatsiya siklining moliyaviy barqarorligini belgilaydi. Ushbu ko'rsatkich sof foydaning umumiy daromadga nisbati sifatida hisoblanadi va daromadning har bir dollari bilan olingan foyda qismini o'lchaydi. Daromad birligiga to'g'ri keladigan sof foyda tendentsiyasi tadqiqot va ishlanmalar (R&D) xarajatlarini boshqarish samaradorligini aks ettiradi. Operatsion richagni baholash uchun investorlarning ushbu tendentsiyani kuzatishi juda muhimdir. Ushbu ko'rsatkichning o'sishi xarajatlar talab qiladigan ishlanmalardan dori vositasining tijorat monetizatsiyasiga o'tishdan signal beradi.

Asosiy raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|DSGN: Sotuvning sof rentabelligi|RCKT: Sof foyda bo'yicha sotuv rentabelligi|FDMT - Sotuvning sof marjinal rentabelligi|LXEO: Sotuvning sof marjinal rentabelligi|Korro Bio Inc. - Sof foyda normasi|EDIT (editasmedicine.com) - Sotuvning sof marjinal rentabelligi|Sof marja SLN|Sof marja ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning sof rentabelligi|Sof marja Sangamo SGMO|NAUT: Sotuvning sof rentabelligi|MGX: Sof foyda bo'yicha sotuv rentabelligi|Sof marja Precision BioSciences|GBIO (generationbio.com) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi IMNN (Imunon, Inc.)|Sotuvning sof marjinal rentabelligi PHIO|MBIO - Sof marja|Sotuvning sof marjinal rentabelligi RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Sof marja|Applied DNA - Sotuvning sof marjinal rentabelligi|Sof marja Bluebird Bio|ImmunoPrecise (IPA) - Sof marja|Sof foyda marjasi OMGA (Omega)|Sof marja Singular Genomics Systems|Sof marja regulusrx.com RGLS|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX